Int Neurourol J.
2015 Sep;19(3):132-132. 10.5213/inj.2015.19.3.132.
Interleukin-33 as a Potential Therapeutic Target for Interstitial Cystitis: New Perspectives on Mast Cell Regulation
- Affiliations
-
- 1Department of Urology, Hallym University College of Medicine, Chuncheon, Korea. snuhuro@gmail.com
- KMID: 2380840
- DOI: http://doi.org/10.5213/inj.2015.19.3.132
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Interleukin-33 and Mast Cells Bridge Innate and Adaptive Immunity: From the Allergologist's Perspective
- Potential Targeting of Siglecs, Mast Cell Inhibitory Receptors, in Interstitial Cystitis
- The Diagnostic Value of Mast Cell Count in Interstitial Cystitis
- New Insights into the Mechanism of the Down-Regulation of Mast Cells in the Treatment of Interstitial Cystitis: Possible Role of Siglecs
- Effects of Immunologically Induced Cystitis on Rat Bladder Histology and Permeability
